0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Therapeutic Nuclear Medicines Market Research Report 2020
Published Date: April 2020
|
Report Code: QYRE-Othe-2A271
Home | Market Reports | Business & Industrial | Pharmaceuticals & Biotech
therapeutic nuclear medicines market

Global Therapeutic Nuclear Medicines Market Research Report 2020

Code: QYRE-Othe-2A271
Report
April 2020
118 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
THERAPEUTIC NUCLEAR MEDICINES MARKET OVERVIEW

 

The global therapeutic nuclear medicines market size is projected at USD 1.208 billion in 2020 to hit USD 3.897 billion by the end of 2026, rising at a CAGR of 18.0% in 2021-2026.

Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.

Therapeutic Nuclear Medicines Market

Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain, and other diseases. The radioactive material of therapeutic nuclear medicines is capable of killing the cancerous tissue, reducing the size of a tumor and reducing pain.

Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.

 

GLOBAL THERAPEUTIC NUCLEAR MEDICINES MARKET: DRIVERS AND RESTRAINS

The research report has incorporated the analysis of different factors that augment the market’s growth. It constitutes trends, restraints, and drivers that transform the market in either a positive or negative manner. This section also provides the scope of different segments and applications that can potentially influence the market in the future. The detailed information is based on current trends and historic milestones. This section also provides an analysis of the volume of production about the global market and also about each type from 2015 to 2026. This section mentions the volume of production by region from 2015 to 2026. Pricing analysis is included in the report according to each type from the year 2015 to 2026, manufacturer from 2015 to 2020, region from 2015 to 2020, and global price from 2015 to 2026.

A thorough evaluation of the restrains included in the report portrays the contrast to drivers and gives room for strategic planning. Factors that overshadow the market growth are pivotal as they can be understood to devise different bends for getting hold of the lucrative opportunities that are present in the ever-growing market. Additionally, insights into market expert’s opinions have been taken to understand the market better.
Market Segment Analysis

The research report includes specific segments by Type and by Application. Each type provides information about the production during the forecast period of 2015 to 2026. Application segment also provides consumption during the forecast period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

 

SEGMENT BY TYPE

  • Radium-223
  • Lutetium-177
  • Iodine-131
  • Other

 

SEGMENT BY APPLICATION

  • Thyroid
  • Bone Metastasis
  • Lymphoma
  • Other

 

GLOBAL THERAPEUTIC NUCLEAR MEDICINES MARKET: REGIONAL ANALYSIS

The report offers an in-depth assessment of the growth and other aspects of the Therapeutic Nuclear Medicines market in important regions, including the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, Taiwan, Southeast Asia, Mexico, and Brazil, etc. Key regions covered in the report are North America, Europe, Asia-Pacific, and Latin America.

The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue, production, and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2015 to 2026. These analyses will help the reader to understand the potential worth of investment in a particular region.

 

GLOBAL THERAPEUTIC NUCLEAR MEDICINES MARKET: COMPETITIVE LANDSCAPE

This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and production by manufacturers during the forecast period of 2015 to 2019.
The major players in the market include Bayer, Novartis AG, China Isotope & Radiation, Dongcheng, Q BioMed, Curium Pharmaceuticals, Jubilant DraxImage, Lantheus, Spectrum Pharmaceuticals, Progenics Pharmaceuticals, International Isotopes, etc.

TABLE OF CONTENT:

 

1 Therapeutic Nuclear Medicines Market Overview

    1.1 Product Overview and Scope of Therapeutic Nuclear Medicines

    1.2 Therapeutic Nuclear Medicines Segment by Type

        1.2.1 Global Therapeutic Nuclear Medicines Production Growth Rate Comparison by Type 2020 VS 2026

        1.2.2 Radium-223

        1.2.3 Lutetium-177

        1.2.4 Iodine-131

        1.2.5 Other

    1.3 Therapeutic Nuclear Medicines Segment by Application

        1.3.1 Therapeutic Nuclear Medicines Consumption Comparison by Application: 2020 VS 2026

        1.3.2 Thyroid

        1.3.3 Bone Metastasis

        1.3.4 Lymphoma

        1.3.5 Other

    1.4 Global Therapeutic Nuclear Medicines Market by Region

        1.4.1 Global Therapeutic Nuclear Medicines Market Size Estimates and Forecasts by Region: 2020 VS 2026

        1.4.2 North America Estimates and Forecasts (2015-2026)

        1.4.3 Europe Estimates and Forecasts (2015-2026)

        1.4.4 China Estimates and Forecasts (2015-2026)

        1.4.5 Japan Estimates and Forecasts (2015-2026)

    1.5 Global Therapeutic Nuclear Medicines Growth Prospects

        1.5.1 Global Therapeutic Nuclear Medicines Revenue Estimates and Forecasts (2015-2026)

        1.5.2 Global Therapeutic Nuclear Medicines Production Capacity Estimates and Forecasts (2015-2026)

        1.5.3 Global Therapeutic Nuclear Medicines Production Estimates and Forecasts (2015-2026)

 

2 Market Competition by Manufacturers

    2.1 Global Therapeutic Nuclear Medicines Production Capacity Market Share by Manufacturers (2015-2020)

    2.2 Global Therapeutic Nuclear Medicines Revenue Share by Manufacturers (2015-2020)

    2.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

    2.4 Global Therapeutic Nuclear Medicines Average Price by Manufacturers (2015-2020)

    2.5 Manufacturers Therapeutic Nuclear Medicines Production Sites, Area Served, Product Types

    2.6 Therapeutic Nuclear Medicines Market Competitive Situation and Trends

        2.6.1 Therapeutic Nuclear Medicines Market Concentration Rate

        2.6.2 Global Top 3 and Top 5 Players Market Share by Revenue

        2.6.3 Mergers & Acquisitions, Expansion

 

3 Production Capacity by Region

    3.1 Global Production Capacity of Therapeutic Nuclear Medicines Market Share by Regions (2015-2020)

    3.2 Global Therapeutic Nuclear Medicines Revenue Market Share by Regions (2015-2020)

    3.3 Global Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2015-2020)

    3.4 North America Therapeutic Nuclear Medicines Production

        3.4.1 North America Therapeutic Nuclear Medicines Production Growth Rate (2015-2020)

        3.4.2 North America Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2015-2020)

    3.5 Europe Therapeutic Nuclear Medicines Production

        3.5.1 Europe Therapeutic Nuclear Medicines Production Growth Rate (2015-2020)

        3.5.2 Europe Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2015-2020)

    3.6 China Therapeutic Nuclear Medicines Production

        3.6.1 China Therapeutic Nuclear Medicines Production Growth Rate (2015-2020)

        3.6.2 China Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2015-2020)

    3.7 Japan Therapeutic Nuclear Medicines Production

        3.7.1 Japan Therapeutic Nuclear Medicines Production Growth Rate (2015-2020)

        3.7.2 Japan Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2015-2020)

 

4 Global Therapeutic Nuclear Medicines Consumption by Regions

    4.1 Global Therapeutic Nuclear Medicines Consumption by Regions

        4.1.1 Global Therapeutic Nuclear Medicines Consumption by Region

        4.1.2 Global Therapeutic Nuclear Medicines Consumption Market Share by Region

    4.2 North America

        4.2.1 North America Therapeutic Nuclear Medicines Consumption by Countries

4.2.2 U.S.

4.2.3 Canada

    4.3 Europe

        4.3.1 Europe Therapeutic Nuclear Medicines Consumption by Countries

4.3.2 Germany

4.3.3 France

4.3.4 U.K.

4.3.5 Italy

4.3.6 Russia

    4.4 Asia Pacific

        4.4.1 Asia Pacific Therapeutic Nuclear Medicines Consumption by Region

4.4.2 China

4.4.3 Japan

4.4.4 South Korea

4.4.5 Taiwan

4.4.6 Southeast Asia

4.4.7 India

4.4.8 Australia

    4.5 Latin America

        4.5.1 Latin America Therapeutic Nuclear Medicines Consumption by Countries

4.5.2 Mexico

4.5.3 Brazil

 

5 Production, Revenue, Price Trend by Type

    5.1 Global Therapeutic Nuclear Medicines Production Market Share by Type (2015-2020)

    5.2 Global Therapeutic Nuclear Medicines Revenue Market Share by Type (2015-2020)

    5.3 Global Therapeutic Nuclear Medicines Price by Type (2015-2020)

    5.4 Global Therapeutic Nuclear Medicines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

 

6 Global Therapeutic Nuclear Medicines Market Analysis by Application

    6.1 Global Therapeutic Nuclear Medicines Consumption Market Share by Application (2015-2020)

    6.2 Global Therapeutic Nuclear Medicines Consumption Growth Rate by Application (2015-2020)

 

7 Company Profiles and Key Figures in Therapeutic Nuclear Medicines Business

    7.1 Bayer

        7.1.1 Bayer Therapeutic Nuclear Medicines Production Sites and Area Served

        7.1.2 Therapeutic Nuclear Medicines Product Introduction, Application and Specification

        7.1.3 Bayer Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2015-2020)

        7.1.4 Main Business and Markets Served

    7.2 Novartis AG

        7.2.1 Novartis AG Therapeutic Nuclear Medicines Production Sites and Area Served

        7.2.2 Therapeutic Nuclear Medicines Product Introduction, Application and Specification

        7.2.3 Novartis AG Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2015-2020)

        7.2.4 Main Business and Markets Served

    7.3 China Isotope & Radiation

        7.3.1 China Isotope & Radiation Therapeutic Nuclear Medicines Production Sites and Area Served

        7.3.2 Therapeutic Nuclear Medicines Product Introduction, Application and Specification

        7.3.3 China Isotope & Radiation Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2015-2020)

        7.3.4 Main Business and Markets Served

    7.4 Dongcheng

        7.4.1 Dongcheng Therapeutic Nuclear Medicines Production Sites and Area Served

        7.4.2 Therapeutic Nuclear Medicines Product Introduction, Application and Specification

        7.4.3 Dongcheng Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2015-2020)

        7.4.4 Main Business and Markets Served

    7.5 Q BioMed

        7.5.1 Q BioMed Therapeutic Nuclear Medicines Production Sites and Area Served

        7.5.2 Therapeutic Nuclear Medicines Product Introduction, Application and Specification

        7.5.3 Q BioMed Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2015-2020)

        7.5.4 Main Business and Markets Served

    7.6 Curium Pharmaceuticals

        7.6.1 Curium Pharmaceuticals Therapeutic Nuclear Medicines Production Sites and Area Served

        7.6.2 Therapeutic Nuclear Medicines Product Introduction, Application and Specification

        7.6.3 Curium Pharmaceuticals Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2015-2020)

        7.6.4 Main Business and Markets Served

    7.7 Jubilant DraxImage

        7.7.1 Jubilant DraxImage Therapeutic Nuclear Medicines Production Sites and Area Served

        7.7.2 Therapeutic Nuclear Medicines Product Introduction, Application and Specification

        7.7.3 Jubilant DraxImage Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2015-2020)

        7.4.4 Main Business and Markets Served

    7.8 Lantheus

        7.8.1 Lantheus Therapeutic Nuclear Medicines Production Sites and Area Served

        7.8.2 Therapeutic Nuclear Medicines Product Introduction, Application and Specification

        7.8.3 Lantheus Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2015-2020)

        7.8.4 Main Business and Markets Served

    7.9 Spectrum Pharmaceuticals

        7.9.1 Spectrum Pharmaceuticals Therapeutic Nuclear Medicines Production Sites and Area Served

        7.9.2 Therapeutic Nuclear Medicines Product Introduction, Application and Specification

        7.9.3 Spectrum Pharmaceuticals Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2015-2020)

        7.9.4 Main Business and Markets Served

    7.10 Progenics Pharmaceuticals

        7.10.1 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Production Sites and Area Served

        7.10.2 Therapeutic Nuclear Medicines Product Introduction, Application and Specification

        7.10.3 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2015-2020)

        7.10.4 Main Business and Markets Served

    7.11 International Isotopes

        7.11.1 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Production Sites and Area Served

        7.11.2 Therapeutic Nuclear Medicines Product Introduction, Application and Specification

        7.11.3 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2015-2020)

        7.11.4 Main Business and Markets Served

        .1 International Isotopes Therapeutic Nuclear Medicines Production Sites and Area Served

        .2 Therapeutic Nuclear Medicines Product Introduction, Application and Specification

        .3 International Isotopes Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2015-2020)

        .4 Main Business and Markets Served

 

8 Therapeutic Nuclear Medicines Manufacturing Cost Analysis

    8.1 Therapeutic Nuclear Medicines Key Raw Materials Analysis

       8.1.1 Key Raw Materials

       8.1.2 Key Raw Materials Price Trend

       8.1.3 Key Suppliers of Raw Materials

    8.2 Proportion of Manufacturing Cost Structure

    8.3 Manufacturing Process Analysis of Therapeutic Nuclear Medicines

    8.4 Therapeutic Nuclear Medicines Industrial Chain Analysis

 

9 Marketing Channel, Distributors, and Customers

    9.1 Marketing Channel

    9.2 Therapeutic Nuclear Medicines Distributors List

    9.3 Therapeutic Nuclear Medicines Customers

 

10 Market Dynamics

10.1 Market Trends

10.2 Opportunities and Drivers

10.3 Challenges

10.4 Porter's Five Forces Analysis

 

11 Production and Supply Forecast

    11.1 Global Forecasted Production of Therapeutic Nuclear Medicines (2021-2026)

    11.2 Global Forecasted Revenue of Therapeutic Nuclear Medicines (2021-2026)

    11.3 Global Forecasted Price of Therapeutic Nuclear Medicines (2021-2026)

    11.4 Global Therapeutic Nuclear Medicines Production Forecast by Regions (2021-2026)

        11.4.1 North America Therapeutic Nuclear Medicines Production, Revenue Forecast (2021-2026)

        11.4.2 Europe Therapeutic Nuclear Medicines Production, Revenue Forecast (2021-2026)

        11.4.3 China Therapeutic Nuclear Medicines Production, Revenue Forecast (2021-2026)

        11.4.4 Japan Therapeutic Nuclear Medicines Production, Revenue Forecast (2021-2026)

 

12 Consumption and Demand Forecast

    12.1 Global Forecasted and Consumption Demand Analysis of Therapeutic Nuclear Medicines

    12.2 North America Forecasted Consumption of Therapeutic Nuclear Medicines by Country

    12.3 Europe Market Forecasted Consumption of Therapeutic Nuclear Medicines by Country

    12.4 Asia Pacific Market Forecasted Consumption of Therapeutic Nuclear Medicines by Regions

    12.5 Latin America Forecasted Consumption of Therapeutic Nuclear Medicines

 

13 Forecast by Type and by Application (2021-2026)

    13.1 Global Production, Revenue and Price Forecast by Type (2021-2026)

        13.1.1 Global Forecasted Production of Therapeutic Nuclear Medicines by Type (2021-2026)

        13.1.2 Global Forecasted Revenue of Therapeutic Nuclear Medicines by Type (2021-2026)

        13.1.2 Global Forecasted Price of Therapeutic Nuclear Medicines by Type (2021-2026)

    13.2 Global Forecasted Consumption of Therapeutic Nuclear Medicines by Application (2021-2026)

 

14 Research Finding and Conclusion

 

15 Methodology and Data Source

15.1 Methodology/Research Approach

15.1.1 Research Programs/Design

15.1.2 Market Size Estimation

15.1.3 Market Breakdown and Data Triangulation

15.2 Data Source

15.2.1 Secondary Sources

15.2.2 Primary Sources

15.3 Author List

15.4 Disclaimer

LIST OF TABLES & FIGURES :

 

Table 1. Global Therapeutic Nuclear Medicines Production (K Units) Growth Rate Comparison by Type (2015-2026)

Table 2. Global Therapeutic Nuclear Medicines Market Size by Type (K Units) (US$ Million) (2020 VS 2026)

Table 3. Global Therapeutic Nuclear Medicines Consumption (K Units) Comparison by Application: 2020 VS 2026

Table 4. Global Therapeutic Nuclear Medicines Production (K Units) by Manufacturers

Table 5. Global Therapeutic Nuclear Medicines Production (K Units) by Manufacturers (2015-2020)

Table 6. Global Therapeutic Nuclear Medicines Production Share by Manufacturers (2015-2020)

Table 7. Global Therapeutic Nuclear Medicines Revenue (Million USD) by Manufacturers (2015-2020)

Table 8. Global Therapeutic Nuclear Medicines Revenue Share by Manufacturers (2015-2020)

Table 9. Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Therapeutic Nuclear Medicines as of 2019)

Table 10. Global Market Therapeutic Nuclear Medicines Average Price (USD/Unit) of Key Manufacturers (2015-2020)

Table 11. Manufacturers Therapeutic Nuclear Medicines Production Sites and Area Served

Table 12. Manufacturers Therapeutic Nuclear Medicines Product Types

Table 13. Global Therapeutic Nuclear Medicines Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14.Mergers & Acquisitions, Expansion

Table 15. Global Therapeutic Nuclear Medicines Capacity (K Units) by Region (2015-2020)

Table 16. Global Therapeutic Nuclear Medicines Production (K Units) by Region (2015-2020)

Table 17. Global Therapeutic Nuclear Medicines Revenue (Million US$) by Region (2015-2020)

Table 18. Global Therapeutic Nuclear Medicines Revenue Market Share by Region (2015-2020)

Table 19. Global Therapeutic Nuclear Medicines Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

Table 20. North America Therapeutic Nuclear Medicines Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

Table 21. Europe Therapeutic Nuclear Medicines Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

Table 22. China Therapeutic Nuclear Medicines Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

Table 23. Japan Therapeutic Nuclear Medicines Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

Table 24. Global Therapeutic Nuclear Medicines Consumption (K Units) Market by Region (2015-2020)

Table 25. Global Therapeutic Nuclear Medicines Consumption Market Share by Region (2015-2020)

Table 26. North America Therapeutic Nuclear Medicines Consumption by Countries (2015-2020) (K Units)

Table 27. Europe Therapeutic Nuclear Medicines Consumption by Countries (2015-2020) (K Units)

Table 28. Asia Pacific Therapeutic Nuclear Medicines Consumption by Countries (2015-2020) (K Units)

Table 29. Latin America Therapeutic Nuclear Medicines Consumption by Countries (2015-2020) (K Units)

Table 30. Global Therapeutic Nuclear Medicines Production (K Units) by Type (2015-2020)

Table 31. Global Therapeutic Nuclear Medicines Production Share by Type (2015-2020)

Table 32. Global Therapeutic Nuclear Medicines Revenue (Million US$) by Type (2015-2020)

Table 33. Global Therapeutic Nuclear Medicines Revenue Share by Type (2015-2020)

Table 34. Global Therapeutic Nuclear Medicines Price (USD/Unit) by Type (2015-2020)

Table 35. Global Therapeutic Nuclear Medicines Consumption (K Units) by Application (2015-2020)

Table 36. Global Therapeutic Nuclear Medicines Consumption Market Share by Application (2015-2020)

Table 37. Global Therapeutic Nuclear Medicines Consumption Growth Rate by Application (2015-2020)

Table 38. Bayer Therapeutic Nuclear Medicines Production Sites and Area Served

Table 39. Bayer Production Sites and Area Served

Table 40. Bayer Therapeutic Nuclear Medicines Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

Table 41. Bayer Main Business and Markets Served

Table 42. Novartis AG Therapeutic Nuclear Medicines Production Sites and Area Served

Table 43. Novartis AG Production Sites and Area Served

Table 44. Novartis AG Therapeutic Nuclear Medicines Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

Table 45. Novartis AG Main Business and Markets Served

Table 46. China Isotope & Radiation Therapeutic Nuclear Medicines Production Sites and Area Served

Table 47. China Isotope & Radiation Production Sites and Area Served

Table 48. China Isotope & Radiation Therapeutic Nuclear Medicines Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

Table 49. China Isotope & Radiation Main Business and Markets Served

Table 50. Dongcheng Therapeutic Nuclear Medicines Production Sites and Area Served

Table 51. Dongcheng Production Sites and Area Served

Table 52. Dongcheng Therapeutic Nuclear Medicines Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

Table 53. Dongcheng Main Business and Markets Served

Table 54. Q BioMed Therapeutic Nuclear Medicines Production Sites and Area Served

Table 55. Q BioMed Production Sites and Area Served

Table 56. Q BioMed Therapeutic Nuclear Medicines Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

Table 57. Q BioMed Main Business and Markets Served

Table 58. Curium Pharmaceuticals Therapeutic Nuclear Medicines Production Sites and Area Served

Table 59. Curium Pharmaceuticals Production Sites and Area Served

Table 60. Curium Pharmaceuticals Therapeutic Nuclear Medicines Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

Table 61. Curium Pharmaceuticals Main Business and Markets Served

Table 62. Jubilant DraxImage Therapeutic Nuclear Medicines Production Sites and Area Served

Table 63. Jubilant DraxImage Production Sites and Area Served

Table 64. Jubilant DraxImage Therapeutic Nuclear Medicines Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

Table 65. Jubilant DraxImage Main Business and Markets Served

Table 66. Lantheus Therapeutic Nuclear Medicines Production Sites and Area Served

Table 67. Lantheus Production Sites and Area Served

Table 68. Lantheus Therapeutic Nuclear Medicines Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

Table 69. Lantheus Main Business and Markets Served

Table 70. Spectrum Pharmaceuticals Therapeutic Nuclear Medicines Production Sites and Area Served

Table 71. Spectrum Pharmaceuticals Production Sites and Area Served

Table 72. Spectrum Pharmaceuticals Therapeutic Nuclear Medicines Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

Table 73. Spectrum Pharmaceuticals Main Business and Markets Served

Table 74. Progenics Pharmaceuticals Therapeutic Nuclear Medicines Production Sites and Area Served

Table 75. Progenics Pharmaceuticals Production Sites and Area Served

Table 76. Progenics Pharmaceuticals Therapeutic Nuclear Medicines Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

Table 77. Progenics Pharmaceuticals Main Business and Markets Served

Table 78. International Isotopes Therapeutic Nuclear Medicines Production Sites and Area Served

Table 79. International Isotopes Production Sites and Area Served

Table 80. International Isotopes Therapeutic Nuclear Medicines Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

Table 81. International Isotopes Main Business and Markets Served

Table 82. Production Base and Market Concentration Rate of Raw Material

Table 83. Key Suppliers of Raw Materials

Table 84. Therapeutic Nuclear Medicines Distributors List

Table 85. Therapeutic Nuclear Medicines Customers List

Table 86. Market Key Trends

Table 87. Key Opportunities and Drivers: Impact Analysis (2021-2026)

Table 88. Key Challenges

Table 89. Global Therapeutic Nuclear Medicines Production (K Units) Forecast by Region (2021-2026)

Table 90. North America Therapeutic Nuclear Medicines Consumption Forecast 2021-2026 (K Units) by Country

Table 91. Europe Therapeutic Nuclear Medicines Consumption Forecast 2021-2026 (K Units) by Country

Table 92. Asia Pacific Therapeutic Nuclear Medicines Consumption Forecast 2021-2026 (K Units) by Regions

Table 93. Latin America Therapeutic Nuclear Medicines Consumption Forecast 2021-2026 (K Units) by Country

Table 94. Global Therapeutic Nuclear Medicines Consumption (K Units) Forecast by Regions (2021-2026)

Table 95. Global Therapeutic Nuclear Medicines Production (K Units) Forecast by Type (2021-2026)

Table 96. Global Therapeutic Nuclear Medicines Revenue (Million US$) Forecast by Type (2021-2026)

Table 97. Global Therapeutic Nuclear Medicines Price (USD/Unit) Forecast by Type (2021-2026)

Table 98. Global Therapeutic Nuclear Medicines Consumption (K Units) Forecast by Application (2021-2026)

Table 99.Research Programs/Design for This Report

Table 100.Key Data Information from Secondary Sources

Table 101.Key Data Information from Primary Sources

List of Figures

Figure 1. Picture of Therapeutic Nuclear Medicines

Figure 2. Global Therapeutic Nuclear Medicines Production Market Share by Type: 2020 VS 2026

Figure 3. Radium-223 Product Picture

Figure 4. Lutetium-177 Product Picture

Figure 5. Iodine-131 Product Picture

Figure 6. Other Product Picture

Figure 7. Global Therapeutic Nuclear Medicines Consumption Market Share by Application: 2020 VS 2026

Figure 8. Thyroid

Figure 9. Bone Metastasis

Figure 10. Lymphoma

Figure 11. Other

Figure 12. North America Therapeutic Nuclear Medicines Revenue (Million US$) and Growth Rate (2015-2026)

Figure 13. Europe Therapeutic Nuclear Medicines Revenue (Million US$) and Growth Rate (2015-2026)

Figure 14. China Therapeutic Nuclear Medicines Revenue (Million US$) and Growth Rate (2015-2026)

Figure 15. Japan Therapeutic Nuclear Medicines Revenue (Million US$) and Growth Rate (2015-2026)

Figure 16. Global Therapeutic Nuclear Medicines Revenue (Million US$) (2015-2026)

Figure 17. Global Therapeutic Nuclear Medicines Production Capacity (K Units) (2015-2026)

Figure 18. Therapeutic Nuclear Medicines Production Share by Manufacturers in 2019

Figure 19. Global Therapeutic Nuclear Medicines Revenue Share by Manufacturers in 2019

Figure 20. Therapeutic Nuclear Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

Figure 21. Global Market Therapeutic Nuclear Medicines Average Price (USD/Unit) of Key Manufacturers in 2019

Figure 22. The Global 5 and 10 Largest Players: Market Share by Therapeutic Nuclear Medicines Revenue in 2019

Figure 23. Global Therapeutic Nuclear Medicines Production Market Share by Region (2015-2020)

Figure 24. Global Therapeutic Nuclear Medicines Production Market Share by Region in 2019

Figure 25. Global Therapeutic Nuclear Medicines Revenue Market Share by Region (2015-2020)

Figure 26. Global Therapeutic Nuclear Medicines Revenue Market Share by Region in 2019

Figure 27. Global Therapeutic Nuclear Medicines Production (K Units) Growth Rate (2015-2020)

Figure 28. North America Therapeutic Nuclear Medicines Production (K Units) Growth Rate (2015-2020)

Figure 29. Europe Therapeutic Nuclear Medicines Production (K Units) Growth Rate (2015-2020)

Figure 30. China Therapeutic Nuclear Medicines Production (K Units) Growth Rate (2015-2020)

Figure 31. Japan Therapeutic Nuclear Medicines Production (K Units) Growth Rate (2015-2020)

Figure 32. Global Therapeutic Nuclear Medicines Consumption Market Share by Region (2015-2020)

Figure 33. Global Therapeutic Nuclear Medicines Consumption Market Share by Region in 2019

Figure 34. North America Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units)

Figure 35. North America Therapeutic Nuclear Medicines Consumption Market Share by Countries in 2019

Figure 36. Canada Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units)

Figure 37. U.S. Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units)

Figure 38. Europe Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units)

Figure 39. Europe Therapeutic Nuclear Medicines Consumption Market Share by Countries in 2019

Figure 40. Germany America Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units)

Figure 41. France Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units)

Figure 42. U.K. Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units)

Figure 43. Italy Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units)

Figure 44. Russia Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units)

Figure 45. Asia Pacific Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units)

Figure 46. Asia Pacific Therapeutic Nuclear Medicines Consumption Market Share by Regions in 2019

Figure 47. China Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units)

Figure 48. Japan Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units)

Figure 49. South Korea Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units)

Figure 50. Taiwan Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units)

Figure 51. Southeast Asia Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units)

Figure 52. India Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units)

Figure 53. Australia Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units)

Figure 54. Latin America Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units)

Figure 55. Latin America Therapeutic Nuclear Medicines Consumption Market Share by Countries in 2019

Figure 56. Mexico Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units)

Figure 57. Brazil Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units)

Figure 58. Production Market Share of Therapeutic Nuclear Medicines by Type (2015-2020)

Figure 59. Production Market Share of Therapeutic Nuclear Medicines by Type in 2019

Figure 60. Revenue Share of Therapeutic Nuclear Medicines by Type (2015-2020)

Figure 61. Revenue Market Share of Therapeutic Nuclear Medicines by Type in 2019

Figure 62. Global Therapeutic Nuclear Medicines Production Growth by Type (2015-2020) (K Units)

Figure 63. Global Therapeutic Nuclear Medicines Consumption Market Share by Application (2015-2020)

Figure 64. Global Therapeutic Nuclear Medicines Consumption Market Share by Application in 2019

Figure 65. Global Therapeutic Nuclear Medicines Consumption Growth Rate by Application (2015-2020)

Figure 66. Price Trend of Key Raw Materials

Figure 67. Manufacturing Cost Structure of Therapeutic Nuclear Medicines

Figure 68. Manufacturing Process Analysis of Therapeutic Nuclear Medicines

Figure 69. Therapeutic Nuclear Medicines Industrial Chain Analysis

Figure 70. Channels of Distribution

Figure 71. Distributors Profiles

Figure 72. Porter's Five Forces Analysis

Figure 73. Global Therapeutic Nuclear Medicines Production Capacity (K Units) and Growth Rate Forecast (2021-2026)

Figure 74. Global Therapeutic Nuclear Medicines Production (K Units) and Growth Rate Forecast (2021-2026)

Figure 75. Global Therapeutic Nuclear Medicines Revenue (Million US$) and Growth Rate Forecast (2021-2026)

Figure 76. Global Therapeutic Nuclear Medicines Price and Trend Forecast (2021-2026)

Figure 77. Global Therapeutic Nuclear Medicines Production Market Share Forecast by Region (2021-2026)

Figure 78. North America Therapeutic Nuclear Medicines Production (K Units) and Growth Rate Forecast (2021-2026)

Figure 79. North America Therapeutic Nuclear Medicines Revenue (Million US$) and Growth Rate Forecast (2021-2026)

Figure 80. Europe Therapeutic Nuclear Medicines Production (K Units) and Growth Rate Forecast (2021-2026)

Figure 81. Europe Therapeutic Nuclear Medicines Revenue (Million US$) and Growth Rate Forecast (2021-2026)

Figure 82. China Therapeutic Nuclear Medicines Production (K Units) and Growth Rate Forecast (2021-2026)

Figure 83. China Therapeutic Nuclear Medicines Revenue (Million US$) and Growth Rate Forecast (2021-2026)

Figure 84. Japan Therapeutic Nuclear Medicines Production (K Units) and Growth Rate Forecast (2021-2026)

Figure 85. Japan Therapeutic Nuclear Medicines Revenue (Million US$) and Growth Rate Forecast (2021-2026)

Figure 86. Global Forecasted and Consumption Demand Analysis of Therapeutic Nuclear Medicines

Figure 87. North America Therapeutic Nuclear Medicines Consumption (K Units) Growth Rate Forecast (2021-2026)

Figure 88. Europe Therapeutic Nuclear Medicines Consumption (K Units) Growth Rate Forecast (2021-2026)

Figure 89. Asia Pacific Therapeutic Nuclear Medicines Consumption (K Units) Growth Rate Forecast (2021-2026)

Figure 90. Latin America Therapeutic Nuclear Medicines Consumption (K Units) Growth Rate Forecast (2021-2026)

Figure 91. Global Therapeutic Nuclear Medicines Production (K Units) Forecast by Type (2021-2026)

Figure 92. Global Therapeutic Nuclear Medicines Revenue Market Share Forecast by Type (2021-2026)

Figure 93. Global Therapeutic Nuclear Medicines Consumption Forecast by Application (2021-2026)

Figure 94. Bottom-up and Top-down Approaches for This Report

Figure 95. Data Triangulation

SELECT A FORMAT
Added to Cart

Electronic (PDF)
$2900
This license allows only one user to access the PDF.

Electronic (PDF)
$5800
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Accenture

RELATED REPORTS

Global and Japan qPCR Kits Market Insights Forecast to 2027
Global and Japan qPCR Kits Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-39Y7542
Wed Nov 24 00:00:00 UTC 2021

Add to Cart

Global and China Human ELISA Kits Market Insights Forecast to 2027
Global and China Human ELISA Kits Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-24Z7484
Wed Nov 24 00:00:00 UTC 2021

Add to Cart

Global and United States PCR Amplifier Market Insights Forecast to 2027
Global and United States PCR Amplifier Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-6W7895
Wed Nov 24 00:00:00 UTC 2021

Add to Cart

Global and China Porcine ELISA Kits Market Insights Forecast to 2027
Global and China Porcine ELISA Kits Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-37N7620
Wed Nov 24 00:00:00 UTC 2021

Add to Cart